Non-syndromic hemimelia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2130
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Non-syndromic hemimelia is a rare congenital limb deficiency characterized by the absence or severe underdevelopment (hypoplasia) of one or more long bones of the limbs, occurring in isolation without other associated syndromic features. The condition is present at birth and can affect either the upper or lower extremities. Hemimelia may involve the radius, ulna, tibia, or fibula, and is classified based on which bone is affected. When described as 'non-syndromic,' it means the limb deficiency occurs without the additional organ system abnormalities, craniofacial anomalies, or other congenital malformations that would suggest a broader genetic syndrome. The musculoskeletal system is primarily affected, and clinical features vary depending on the specific bone involved and the degree of deficiency. Patients may present with limb length discrepancy, joint instability, angular deformity, and functional impairment of the affected limb. Associated findings can include absence or hypoplasia of adjacent structures such as fingers or toes, and contractures of nearby joints. The condition can be unilateral or bilateral. Management is multidisciplinary and typically involves orthopedic surgery, prosthetics, and rehabilitation. Treatment strategies depend on the severity and location of the deficiency and may include limb lengthening procedures, corrective osteotomies, reconstructive surgery, or in some cases amputation with prosthetic fitting to optimize function. Physical and occupational therapy play important roles in maximizing mobility and independence. The underlying etiology in most sporadic cases remains unclear, though both genetic and environmental factors have been implicated.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Non-syndromic hemimelia.

View clinical trials →

No actively recruiting trials found for Non-syndromic hemimelia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Non-syndromic hemimelia community →

No specialists are currently listed for Non-syndromic hemimelia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Non-syndromic hemimelia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Non-syndromic hemimeliaForum →

No community posts yet. Be the first to share your experience with Non-syndromic hemimelia.

Start the conversation →

Latest news about Non-syndromic hemimelia

No recent news articles for Non-syndromic hemimelia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Non-syndromic hemimelia

What is Non-syndromic hemimelia?

Non-syndromic hemimelia is a rare congenital limb deficiency characterized by the absence or severe underdevelopment (hypoplasia) of one or more long bones of the limbs, occurring in isolation without other associated syndromic features. The condition is present at birth and can affect either the upper or lower extremities. Hemimelia may involve the radius, ulna, tibia, or fibula, and is classified based on which bone is affected. When described as 'non-syndromic,' it means the limb deficiency occurs without the additional organ system abnormalities, craniofacial anomalies, or other congenital

At what age does Non-syndromic hemimelia typically begin?

Typical onset of Non-syndromic hemimelia is neonatal. Age of onset can vary across affected individuals.